126 related articles for article (PubMed ID: 28838033)
1. Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis.
Ji JH; Kim YS; Park I; Lee SI; Kim RB; Park JO; Oh SY; Hwang IG; Jang JS; Song HN; Kang JH
Cancer Res Treat; 2018 Jul; 50(3):791-800. PubMed ID: 28838033
[TBL] [Abstract][Full Text] [Related]
2. Natural history of metastatic biliary tract cancer (BTC) patients with good performance status (PS) who were treated with only best supportive care (BSC).
Ji JH; Song HN; Kim RB; Oh SY; Lim HY; Park JO; Park SH; Kim MJ; Lee SI; Ryou SH; Hwang IG; Jang JS; Kim HJ; Choi JY; Kang JH
Jpn J Clin Oncol; 2015 Mar; 45(3):256-60. PubMed ID: 25628352
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
Chiorean EG; Ramasubbaiah R; Yu M; Picus J; Bufill JA; Tong Y; Coleman N; Johnston EL; Currie C; Loehrer PJ
Oncologist; 2012; 17(1):13. PubMed ID: 22210086
[TBL] [Abstract][Full Text] [Related]
4. Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy.
Ikezawa K; Kanai M; Ajiki T; Tsukamoto T; Toyokawa H; Terajima H; Furuyama H; Nagano H; Ikai I; Kuroda N; Awane M; Ochiai T; Takemura S; Miyamoto A; Kume M; Ogawa M; Takeda Y; Taira K; Ioka T
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):98-104. PubMed ID: 23798367
[TBL] [Abstract][Full Text] [Related]
5. Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016.
Wang J; Bo X; Nan L; Wang CC; Gao Z; Suo T; Ni X; Liu H; Lu P; Wang Y; Liu H
Cancer Med; 2020 Feb; 9(4):1335-1348. PubMed ID: 31876990
[TBL] [Abstract][Full Text] [Related]
6. An age-group analysis on the efficacy of chemotherapy in older adult patients with metastatic biliary tract cancer: a Japanese cancer registry cohort study.
Hirao T; Ikezawa K; Morishima T; Daiku K; Seiki Y; Watsuji K; Kawamoto Y; Higashi S; Urabe M; Kai Y; Takada R; Yamai T; Mukai K; Nakabori T; Uehara H; Miyashiro I; Ohkawa K
BMC Gastroenterol; 2023 Aug; 23(1):263. PubMed ID: 37528334
[TBL] [Abstract][Full Text] [Related]
7. Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
Moik F; Riedl JM; Winder T; Terbuch A; Rossmann CH; Szkandera J; Bauernhofer T; Kasparek AK; Schaberl-Moser R; Reicher A; Prinz F; Pichler M; Stöger H; Stotz M; Gerger A; Posch F
Sci Rep; 2019 Apr; 9(1):5548. PubMed ID: 30944390
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer.
Gbolahan OB; Zhi X; Liu Y; Shah MM; Kooby DA; Alese OB
JAMA Netw Open; 2024 Jan; 7(1):e2351502. PubMed ID: 38206623
[TBL] [Abstract][Full Text] [Related]
9. Older adults with biliary tract cancer: treatment and prognosis.
Lee BS; Hwang JH; Lee SH; Jang SE; Ahn DW; Hwang DW; Cho JY; Yoon YS; Han HS; Ahn S
J Am Geriatr Soc; 2012 Oct; 60(10):1862-71. PubMed ID: 23035728
[TBL] [Abstract][Full Text] [Related]
10. The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancer: A STROBE-compliant retrospective cohort study.
Yin L; Xu Q; Li J; Wei Q; Ying J
Medicine (Baltimore); 2018 Dec; 97(50):e13570. PubMed ID: 30558021
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.
Haas M; Heinemann V; Kullmann F; Laubender RP; Klose C; Bruns CJ; Holdenrieder S; Modest DP; Schulz C; Boeck S
J Cancer Res Clin Oncol; 2013 Apr; 139(4):681-9. PubMed ID: 23315099
[TBL] [Abstract][Full Text] [Related]
12. The impact of age and comorbidity in advanced or recurrent biliary tract cancer receiving palliative chemotherapy.
Takahara N; Nakai Y; Saito K; Sasaki T; Suzuki Y; Inokuma A; Oyama H; Kanai S; Suzuki T; Sato T; Hakuta R; Ishigaki K; Saito T; Hamada T; Mizuno S; Kogure H; Tada M; Isayama H; Koike K
J Gastroenterol Hepatol; 2020 Oct; 35(10):1828-1835. PubMed ID: 32267557
[TBL] [Abstract][Full Text] [Related]
13. Impact of palliative chemotherapy and best supportive care on overall survival and length of hospitalization in patients with incurable Cancer: a 4-year single institution experience in Japan.
Murakawa Y; Sakayori M; Otsuka K
BMC Palliat Care; 2019 Jun; 18(1):45. PubMed ID: 31159782
[TBL] [Abstract][Full Text] [Related]
14. Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status.
Ikeda S; Yoshioka H; Ikeo S; Morita M; Sone N; Niwa T; Nishiyama A; Yokoyama T; Sekine A; Ogura T; Ishida T
BMC Cancer; 2017 Nov; 17(1):797. PubMed ID: 29183294
[TBL] [Abstract][Full Text] [Related]
15. The Glasgow Prognostic Score accurately predicts survival in patients with biliary tract cancer not indicated for surgical resection.
Iwaku A; Kinoshita A; Onoda H; Fushiya N; Nishino H; Matsushima M; Tajiri H
Med Oncol; 2014 Jan; 31(1):787. PubMed ID: 24310810
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
Saisho T; Okusaka T; Ueno H; Morizane C; Okada S
Hepatogastroenterology; 2005; 52(66):1654-8. PubMed ID: 16334750
[TBL] [Abstract][Full Text] [Related]
17. Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study.
Kus T; Aktas G; Kalender ME; Sevinc A; Camci C
J Gastrointest Cancer; 2017 Jun; 48(2):170-175. PubMed ID: 27714651
[TBL] [Abstract][Full Text] [Related]
18. CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy.
Lee DW; Im SA; Kim YJ; Yang Y; Rhee J; Na II; Lee KH; Kim TY; Han SW; Choi IS; Oh DY; Kim JH; Kim TY; Bang YJ
Cancer Res Treat; 2017 Jul; 49(3):807-815. PubMed ID: 28111425
[TBL] [Abstract][Full Text] [Related]
19. Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States.
Agarwal R; Sendilnathan A; Siddiqi NI; Gulati S; Ghose A; Xie C; Olowokure OO
J Gastrointest Oncol; 2016 Dec; 7(6):996-1003. PubMed ID: 28078124
[TBL] [Abstract][Full Text] [Related]
20. Poor Prognosis of Advanced Cholangiocarcinoma: Real-World Data from a Tertiary Referral Center.
Koch C; Franzke C; Bechstein WO; Schnitzbauer AA; Filmann N; Vogl T; Gruber-Rouh T; Zeuzem S; Waidmann O; Trojan J
Digestion; 2020; 101(4):458-465. PubMed ID: 31129660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
